Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Bullboard Posts
Comment by Snowballgrowthon Aug 19, 2020 4:44pm
85 Views
Post# 31430628

RE:RE:RE:Paladin’s overnight success took 19 years

RE:RE:RE:Paladin’s overnight success took 19 years
Benedict16th wrote: Gud is not, was not and never will be Pladin. GUD started with a ton of cash and has failled so far. Paladin start with nearly zero cash and achieved unparallel success though when it sold it self the market in biotech was in a state  of irreational exzuberance "over priced". The bottom visible reality to most investors is that the share price of GUD has been going down and in the opposite direction of the overall market. Therefore there must be material intangible facts that the overall market knows and does not like it. You cannot argue with the fact that when the share price of a company is going down is not and never will be a positice a sign of for most if not all investrors ecept for a few on this board. It is not a vote of confidence of MNGT like it or not. Therefore, as I argued before this MNGT team needs to change their mode of operandi yesterday or be replaced sooner than later . Why they do not get it is a mystery to me. Short sellers get it. Thus GUD has become the market maker with "buy back"
Sadly and regretably Meir is slowly being prove correct . I taught I would never say such. 


There are also much more competitors in the Canadian market now : HLS, Cipher, RX, VPH, MDP ... and many private companies

Bullboard Posts